| 書(shū)目名稱(chēng) | Pediatric Cancer Therapeutics Development | | 編輯 | Jorge DiMartino,Gregory H. Reaman,Franklin O. Smit | | 視頻video | http://file.papertrans.cn/743/742996/742996.mp4 | | 概述 | Thorough overview of medical, regulatory, and economic considerations relevant to therapeutics development.Offers a firm grounding in the drug development process.Authors from academic, government, an | | 叢書(shū)名稱(chēng) | Pediatric Oncology | | 圖書(shū)封面 |  | | 描述 | This book provides a comprehensive overview of the scientific, medical, regulatory, and economic considerations associated with the discovery, development, and delivery of novel therapeutics for children with cancer. Co-authored by a diverse team from academic, government, and industry backgrounds, the book describes the steps in the process from the identification of a promising therapeutic target to the evaluation of drug candidates in the various phases of clinical testing and regulatory review. Throughout, special emphasis is placed on the unique biology of pediatric malignancies and the medical and social needs of children and their families. In providing a firm grounding in the drug development process, the book will be of value to all with an interest in how medicines currently used to treat pediatric cancer were made available. This includes trainees as well as established practitioners and others participating in translational and clinical research in the academic setting. | | 出版日期 | Book 2022 | | 關(guān)鍵詞 | Study Design and Biostatistics; Immunotherapy for Pediatric Cancer; Economics of Cancer Therapeutics D | | 版次 | 1 | | doi | https://doi.org/10.1007/978-3-031-06357-2 | | isbn_softcover | 978-3-031-06359-6 | | isbn_ebook | 978-3-031-06357-2Series ISSN 1613-5318 Series E-ISSN 2191-0812 | | issn_series | 1613-5318 | | copyright | Springer Nature Switzerland AG 2022 |
The information of publication is updating
|
|
|Archiver|手機(jī)版|小黑屋|
派博傳思國(guó)際
( 京公網(wǎng)安備110108008328)
GMT+8, 2025-10-14 17:31
發(fā)表于 2025-3-21 17:02:50
